Skip to content

Combo Bio-Engineered Sirolimus Eluting Stent Placement Long-Term Healing Pattern Assessment by Optical Coherence Tomography

Combo Bio-Engineered Sirolimus Eluting Stent Placement Long-Term Healing Pattern Assessment by Optical Coherence Tomography - COMBO Healing

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON41146
Enrollment
40
Registered
2014-12-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

incidence of intracoronary thrombi and late loss neointimal morphology Strut coverage (binary and thickness) strut malapposition

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. The patient must be *18 and * 80 years of age; 2. Device and procedural success at the index procedure; 3. The Patient is willing to comply with specified follow-up evaluations; 4. The Patient or legally authorized representative has been informed of the nature of the study, agrees to its provisions and has been provided written informed consent, approved by the appropriate Medical Ethics Committee (MEC), Institutional Review Board (IRB), or Human Research Ethics Committee (HREC).

Exclusion criteria

Exclusion criteria: 1. Pregnant or nursing patients and those who plan pregnancy in the period up to 1 year following index procedure. Female patients of childbearing potential must have a negative pregnancy test done within 7 days prior to the index procedure per site standard test; 2. Impaired renal function (serum creatinine >2.0 mg/dL or 177 *mol/l) or on dialysis; 3. Platelet count 700,000 cells/mm3 or a WBC1 overlapping Combo stent at the index procedure; 15. Patient with unsuitable anatomy for OCT (tortious, heavily calcified, small distal stent).

Design outcomes

Primary

MeasureTime frame
For all analyses the findings at each individual timepoint and the * between timepoints will be assesed - OCT findings on strut coverage (binary and thickness), neointimal morphology, strut malapposition, incidence of intracoronary thrombi and late loss (late tissue growth, plaque volume, lumen cross sectional area). - Quantitative Coronary Angiography analyses of minimal lumen diameter, mean lumen diameter, maximum percent stenosis, mean stenosis and late lumen loss.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)